if there's a problem in the cost of drugs and cancer drugs, it's all the private oncology practices being purchased by hospital systems--DSH hospitals who then get a 50 percent break from the pharmaceutical companies on these expensive drugs.
Highlights the issue of hospital systems profiting from discounted cancer drugs.
Share
More from Chris Collins
I can't say I feel sorry for the American taxpayers who are bearing this financial burden who were deceived from day one.
I think there's lessons learned in that, when you're good stewards of taxpayer money, the taxpayers expect a level of scrutiny at least consistent with what big banks do when they make loans.
I am somewhat astounded that that vulnerability exists. That should be an immediate disqualifier.
If we can't pay our way now, what are we doing in borrowing on the backs of our children and grandchildren? It is just fundamentally immoral.
Other voices in this conversation
